Security key
09061G101
BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN)
CUSIP: 09061G101
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 192,632,743
- Total 13F shares
- 183,566,055
- Share change
- -5,956,857
- Total reported value
- $10,363,518,231
- Put/Call ratio
- 74%
- Price per share
- $56.49
- Number of holders
- 549
- Value change
- -$373,583,023
- Number of buys
- 284
- Number of sells
- 226
Report period
Q1 2026
Institutions
549
Top holders
10
BMRN full security history
Previous quarter: Q4 2025
BIOMARIN PHARMACEUTICAL INC SEC filings
BIOMARIN PHARMACEUTICAL INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 09061G101
Recent filing periods:
Top shareholders of BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
|
Company |
9.1%
from 13D/G
|
19,135,108
|
$1,137,199,439 | — | 31 Dec 2025 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13D/G
13F
|
Company |
8.2%
|
15,795,383
|
$906,812,938 | $0 | 30 Jun 2025 | |
| VANGUARD CAPITAL MANAGEMENT LLC |
13D/G
|
Vanguard Capital Management |
5.2%
|
10,113,219
|
$571,295,741 | $0 | 31 Mar 2026 | |
| Capital Research Global Investors |
13D/G
13F
|
Company |
4.8%
|
9,150,655
|
$576,308,252 | -$241,913,549 | 31 Mar 2025 | |
| VIKING GLOBAL INVESTORS LP |
13D/G
13F
|
Company |
4.3%
|
8,322,179
|
$450,729,215 | -$214,821,957 | 30 Sep 2025 | |
| Richard A. Meier |
3/4/5
|
Director |
0.07%
|
126,926
|
$7,659,984 | — | 31 Dec 2025 | |
| Robert J. Hombach |
3/4/5
|
Director |
0.02%
|
41,870
|
$2,636,972 | — | 20 May 2025 | |
| Willard H. Dere |
3/4/5
|
Director |
0.02%
|
38,950
|
$2,453,071 | — | 20 May 2025 | |
| Elizabeth M. Anderson |
3/4/5
|
Director |
0.02%
|
34,450
|
$2,169,661 | — | 20 May 2025 | |
| Maykin Ho |
3/4/5
|
Director |
0.01%
|
28,010
|
$1,764,069 | — | 20 May 2025 | |
| Barbara W. Bodem |
3/4/5
|
Director |
0.01%
|
13,555
|
$853,693 | — | 20 May 2025 | |
| Athena Countouriotis |
3/4/5
|
Director |
0.01%
|
13,550
|
$853,379 | — | 20 May 2025 | |
| Mark J. Enyedy |
3/4/5
|
Director |
0.01%
|
13,550
|
$853,379 | — | 20 May 2025 | |
| Timothy P. Walbert |
3/4/5
|
Director |
0.01%
|
10,196
|
$642,143 | — | 20 May 2025 | |
| Ian T. Clark |
3/4/5
|
Director |
0%
|
7,000
|
$401,870 | — | 01 Aug 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
9.4%
|
18,127,847
|
$1,077,337,946 | — | 31 Dec 2025 | |
| DODGE & COX |
13F
|
Company |
7.6%
|
14,572,384
|
$866,036,781 | — | 31 Dec 2025 | |
| NORGES BANK |
13F
|
Company |
3.9%
|
7,531,080
|
$447,572,084 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
3.9%
|
7,523,218
|
$447,104,846 | — | 31 Dec 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
3.5%
|
6,686,916
|
$395,196,725 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.9%
|
3,674,089
|
$218,394,606 | — | 31 Dec 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.7%
|
3,321,754
|
$197,404,798 | — | 31 Dec 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.6%
|
3,037,616
|
$180,525,519 | — | 31 Dec 2025 | |
| Vestal Point Capital, LP |
13F
|
Company |
1.6%
|
3,000,000
|
$178,290,000 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.2%
|
2,315,620
|
$137,617,375 | — | 31 Dec 2025 | |
| Deep Track Capital, LP |
13F
|
Company |
1.2%
|
2,300,000
|
$136,689,000 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
1.1%
|
2,211,721
|
$131,442,578 | — | 31 Dec 2025 | |
| FMR LLC |
13F
|
Company |
0.95%
|
1,837,071
|
$109,177,147 | — | 31 Dec 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.95%
|
1,828,344
|
$108,658,484 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.8%
|
1,547,965
|
$91,995,561 | — | 31 Dec 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.76%
|
1,465,198
|
$87,076,480 | — | 31 Dec 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.75%
|
1,436,639
|
$85,379,456 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.74%
|
1,423,712
|
$84,611,204 | — | 31 Dec 2025 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.74%
|
1,419,067
|
$84,335,152 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.71%
|
1,364,691
|
$81,103,586 | — | 31 Dec 2025 | |
| DnB Asset Management AS |
13F
|
Company |
0.71%
|
1,359,549
|
$80,797,997 | — | 31 Dec 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.69%
|
1,324,971
|
$78,743,027 | — | 31 Dec 2025 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.69%
|
1,320,000
|
$78,447,600 | — | 31 Dec 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.67%
|
1,283,622
|
$76,426,918 | — | 31 Dec 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.64%
|
1,230,254
|
$73,113,998 | — | 31 Dec 2025 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.61%
|
1,166,799
|
$69,342,904 | — | 31 Dec 2025 | |
| LOS ANGELES CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.58%
|
1,111,698
|
$57,708,242 | — | 31 Dec 2025 | |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC |
13F
|
Company |
0.54%
|
1,048,841
|
$62,332,621 | — | 31 Dec 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.52%
|
1,004,029
|
$59,669,443 | — | 31 Dec 2025 | |
| Brandywine Global Investment Management, LLC |
13F
|
Company |
0.49%
|
945,847
|
$56,211,687 | — | 31 Dec 2025 | |
| Pacer Advisors, Inc. |
13F
|
Company |
0.49%
|
937,356
|
$55,707,067 | — | 31 Dec 2025 | |
| River Road Asset Management, LLC |
13F
|
Company |
0.47%
|
906,366
|
$53,865,331 | — | 31 Dec 2025 | |
| LSV ASSET MANAGEMENT |
13F
|
Company |
0.46%
|
882,200
|
$52,429,000 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.45%
|
864,512
|
$51,377,963 | — | 31 Dec 2025 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.44%
|
850,781
|
$50,559,939 | — | 31 Dec 2025 |
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) as of Q1 2026
As of 31 Mar 2026,
BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) was held by
549 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
183,566,055 shares.
The largest 10 holders included
BlackRock, Inc., Dodge & Cox, PRIMECAP MANAGEMENT CO/CA/, VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD PORTFOLIO MANAGEMENT LLC, AQR CAPITAL MANAGEMENT LLC, STATE STREET CORP, VIKING GLOBAL INVESTORS LP, CITADEL ADVISORS LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
549
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
534
Q1 2026 holders
549
Holder diff
15
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.